4
MARCH 2016
BUSINESS SPOTLIGHT
Kansas Regenerative
Medicine Center
Enhancing quality of life through stem cell therapy
Located in Manhattan, the Kansas Regenerative Medicine Center (KRMC) is one of the
only stand-alone stem cell centers in the U.S. Born from the life-changing stem cell therapy
its founders received, KRMC helps ease the pain and immobility associated with various
inflammatory and degenerative conditions by deploying a person’s own stem cells.
World-Class Care
Co-founders John Farley and Ken Woods have had nine knee
surgeries between them. At one point, the men were no longer
able to fully enjoy sports, work on the ranch, or play with their
grandchildren. They finally decided that living in constant pain
and taking daily medications was no longer acceptable, and
sought other options.
After hearing a lecture by an animal stem cell expert about
the amazing successes of animal stem cell therapy, they asked,
“Could this work for us?” Farley and Woods decided it was
worth a try, and both successfully received adipose stem cell
therapy. After waiting several months to confirm their pain relief
was genuine and lasting, they wanted to share their success with
other sufferers. They opened KRMC in March 2014.
KRMC is an affiliate of the Cell Surgical Network (CSN), with
more than 40 of the top multidisciplinary physicians in the world
working together under strict Institutional Review Board guide-
lines. The network shares case information and assists affiliates
with unique cases to best serve patients.
Kate Farley-Cisneros, Director of Marketing & Business
Development at KRMC, notes, “We are an advanced stem
cell therapy center offering treatments that use a person’s own
fat, which is easy and safe to harvest under local anesthesia
and abundantly available. Typically the entire procedure takes
under four hours, and with no stitches. Stem cells have the
amazing ability to differentiate and replicate - they can turn
into bone, cartilage, muscle, fat, collagen, neural tissue, blood
vessels, and more. Adult stem cells appear to be particularly
effective in improving painful joints, replacing cartilage and
ligaments, and even painful conditions along the spine. We’ve
also had some reports of improvement in different areas
anywhere from stroke victims to conditions such as asthma,
fibrosis, vertigo, and more.
The average KRMC patient typically has two to three joints treated.
They range in age from 14 to 90, with most being in their forties
through seventies. KRMC receives patients from around the
world, and their success rate is so good that 60 to 70 percent of
patients come from referrals. KRMC President Pat Farley notes,
“We make sure each patient feels like they are the most impor-
tant person on the planet. It’s rewarding to give them hope.”
(L to R) Frank C. Lyons, MD, Andrew Pope, MD, Steven Peloquin, MD